Another Biotech Bites the Dust as Cambridge's Raze Shuts Down Post author:Sam Post published:December 13, 2017 Post category:BioPharma Reportedly, Raze Therapeutics, a biotech launched in 2014, has closed its doors. Source: BioSpace You Might Also Like Japan's Astellas Pays $102.5M for U.S. Biotech Universal Cells February 13, 2018 Nemaura Medical Develops Rechargeable Transmitter For Sugarbeat July 31, 2017 $710M Gamble Fails as Celgene Terminates Two Phase III Trials October 19, 2017
